EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access

Influenza-Associated Acute Necrotizing Encephalopathy in US Children

Influenza-Associated Acute Necrotizing Encephalopathy (IA-ANE) Working Group, Andrew Silverman, Rachel Walsh, Jonathan D Santoro, Katherine Thomas, Elizabeth Ballinger, Kristen S Fisher, Ajay X Thomas, Brian Appavu, Michael C Kruer, Derek Neilson, Jasmine Knoll und 48 weitere

JAMA · 26.08.2025 · 334 (8) · 692

DOI: 10.1001/jama.2025.11534 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JAMA, erschienen am 26.08.2025. Verfasst von Influenza-Associated Acute Necrotizing Encephalopathy (IA-ANE) Working Group und 59 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Neurology and Neuroimmunology, Lucile Packard Children's Hospital, Stanford University, Palo Alto, California. Hauptthemen laut MEDLINE: Influenza Vaccines, Influenza, Human, Leukoencephalitis, Acute Hemorrhagic. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Acute necrotizing encephalopathy (ANE) is a rare, but severe, neurologic condition for which epidemiologic and management data remain limited. During the 2024-2025 US influenza season, clinicians at large pediatric centers anecdotally reported an increased number of children with influenza-associated ANE, prompting this national investigation.

Objective

To understand the clinical presentation, interventions, and outcomes among US children diagnosed with influenza-associated ANE. Design, Setting, and Participants This study was a multicenter case series of children diagnosed with ANE with longitudinal follow-up. A call for cases was issued via academic societies, public health agencies, and by directly contacting pediatric specialists at 76 US academic centers, requesting cases between October 1, 2023, and May 30, 2025. Inclusion criteria required acute encephalopathy with radiologic evidence of acute thalamic injury and laboratory confirmation of influenza infection in individuals aged 21 years or younger. Exposure Influenza-associated ANE. Main Outcomes and Measures Presenting symptoms, vaccination history, laboratory and genetic findings, interventions, and clinical outcomes, including modified Rankin Scale score (0: no symptoms; 1-2: mild disability; 3-5: moderate to severe disability; 6: death), length of stay, and functional outcomes.

Results

Of 58 submitted cases, 41 cases (23 females; median age, 5 years [IQR, 2-8]) from 23 US hospitals met inclusion criteria. Thirty-one cases (76%) had no significant medical history; 5 (12%) were medically complex. Clinical presentation included fever in 38 patients (93%), encephalopathy in 41 (100%), and seizures in 28 (68%). Thirty-nine patients (95%) had influenza A (14 with A/H1pdm/2009, 7 with A/H3N2, and 18 with no subtype) and 2 had influenza B. Laboratory deviations included elevated liver enzymes (78%), thrombocytopenia (63%), and elevated cerebrospinal fluid protein (63%). Among 32 patients (78%) with genetic testing, 15 (47%) had genetic risk alleles potentially related to risk of ANE including 11 (34%) with RANBP2 variants. Among 38 patients with available vaccination history, only 6 (16%) had received age-appropriate seasonal influenza vaccination. Most patients received multiple immunomodulatory treatments, including methylprednisolone (95%), intravenous immunoglobulin (66%), tocilizumab (51%), plasmapheresis (32%), anakinra (5%), and intrathecal methylprednisolone (5%). Median intensive care unit and hospital lengths of stay were 11 days (IQR, 4-19) and 22 days (IQR, 7-36), respectively. Eleven patients (27%) died a median of 3 days (IQR, 2-4) from symptom onset, primarily from cerebral herniation (91%). Among the 27 survivors with 90-day follow-up, 63% had at least moderate disability (modified Rankin Scale score ≥3). Conclusions and Relevance In this case series of children with influenza-associated ANE from the 2 most recent influenza seasons in the US, the condition was associated with high morbidity and mortality in this cohort of predominantly young and previously healthy children. The findings emphasize the need for prevention, early recognition, intensive treatment, and standardized management protocols.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza VaccinesInfluenza, HumanLeukoencephalitis, Acute HemorrhagicChildChild, PreschoolFemaleHumansMaleUnited StatesDisability EvaluationLength of StayImmunomodulating AgentsPlasmapheresisIntensive Care UnitsInfluenza A virusInfluenza B virusEarly DiagnosisHospital MortalityLongitudinal StudiesFollow-Up Studies

Substanzen

Influenza VaccinesImmunomodulating Agents

Autor:innen und Institutionen

  • Pediatric Neurology and Neuroimmunology, Lucile Packard Children's Hospital, Stanford University, Palo Alto, California.
  • Department of Neurology and Pediatric Neuroimmunology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Pediatric Neuroimmunology, Children's Hospital Los Angeles, Keck School of Medicine of USC, Los Angeles, California.
  • Pediatric Rehabilitation Medicine, Santa Clara Valley Medical Center, San Jose, California.
  • Department of Pediatrics, Division of Neurology and Developmental Neuroscience, Baylor College of Medicine at Texas Children's Hospital, Houston.
  • Pediatric Neuroimmunology and Neurogenetics, Neurocritical Care, Genetics and Metabolism, Barrow Neurological Institute at Phoenix Children's, University of Arizona School of Medicine, Phoenix.

Förderung

  • NIAID NIH HHS

Zitieren

APA

Influenza-Associated Acute Necrotizing Encephalopathy (IA-ANE) Working Group, Silverman, A., Walsh, R., Santoro, J. D., Thomas, K., Ballinger, E., Fisher, K. S., Thomas, A. X., Appavu, B., Kruer, M. C., Neilson, D., Knoll, J., Sharp, A. N., Edelman, H. E., Otallah, S., Morgan, A., Grzezulkowska, A., Nguyen, J., Rao, L. M., …, & LaRocca, T. (2025). Influenza-Associated Acute Necrotizing Encephalopathy in US Children. JAMA, 334(8), 692. https://doi.org/10.1001/jama.2025.11534

Vancouver

Influenza-Associated Acute Necrotizing Encephalopathy (IA-ANE) Working Group, Silverman A, Walsh R, Santoro JD, Thomas K, Ballinger E, et al. Influenza-Associated Acute Necrotizing Encephalopathy in US Children. JAMA. 2025;334(8):692. doi:10.1001/jama.2025.11534

BibTeX
@article{InfluenzaAssociatedAcuteNecrotizingEncephalopathyIAANEWorkingGroup2025,
  author = {Influenza-Associated Acute Necrotizing Encephalopathy (IA-ANE) Working Group, Influenza-Associated Acute Necrotizing Encephalopathy (IA-ANE) Working Group and Silverman, Andrew and Walsh, Rachel and Santoro, Jonathan D and Thomas, Katherine and Ballinger, Elizabeth and Fisher, Kristen S and Thomas, Ajay X and Appavu, Brian and Kruer, Michael C and Neilson, Derek and Knoll, Jasmine and Sharp, April N and Edelman, Hannah E and Otallah, Scott and Morgan, Alexandra and Grzezulkowska, Aniela and Nguyen, John and Rao, Lekha M and Hecht, Shaina M and Catalano, Laura and Daigle, Hunter and Kronfol, Catherine and Wharton, Jessica and Adams, David and Kalawi, Adam Z and Kung, Michael and Arellano, Janetta L and Smith, Lauren and Segal, Devorah and Feja, Kristina and Broomall, Eileen and Jayakar, Anuj and Arnold, Sandra R and Retallack, Hanna and Press, Craig A and Gombolay, Grace and McLaughlin, Madeleine H and Kannan, Varun and Thakkar, Kavita and Rezwan, Tasmia and Hulfish, Erin and Eid, Dalia and Meylor, Jennifer and Peng, Diane and Hurtado, Ryan and Nickerson, Taylor and Mandell, Iris and Carbonell, Abigail U and Kerner-Rossi, Mallory and Jayaraman, Divya and Davis, Mallory and Olivero, Rosemary and Shah, Neel and Osborne, Christina M and Zhang, Bo and Cortina, Christopher and Randolph, Adrienne G and Rao, Suchitra and LaRocca, Thomas},
  title = {Influenza-Associated Acute Necrotizing Encephalopathy in US Children},
  journal = {JAMA},
  year = {2025},
  volume = {334},
  number = {8},
  pages = {692},
  doi = {10.1001/jama.2025.11534}
}
Kostenlos starten →